AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: William Patalon III
Dec. 6--Yesterday's disclosure that the U.S. supplies of flu vaccines may run short could give a short-term boost to MedImmune Inc.'s so-far disappointing FluMist nasal-spray flu vaccine.
But the Gaithersburg, Md.-based company and its marketing partner will have to slash the vaccine's high price if the new product is to achieve long-term success, according to an analyst who follows MedImmune.
Aventis SA of France, the largest maker of flu vaccines, and Chiron Corp., of California, said yesterday that reports that a more virulent strain of the influenza virus was circulating this year had spurred more people to seek…
Source: HighBeam Research, Vaccine Shortage to Boost FluMist Sales for Gaithersburg, Md.-Based...